ALT · Altimmune, Inc.
$2.94
+0.06 (+2.08%)
At close · Aug 14
Market Cap
$571.88M
Shares
194.52M
Positioning
Aug 21, 2026 · 5 days to expiryPut / call OI
—
dated and unknown snapshot sessions
Open interest
—
dated and unknown snapshot sessions
Volume
—
dated and unknown snapshot sessions
Chain
Click any strike for greeks, breakeven and the calculator
Expiry
Aug 21 5d
Aug 28 12d
Sep 4 19d
Sep 11 26d
Sep 18 33d
Sep 25 40d
Oct 2 47d
Dec 18 124d
Jan 15 152d
Mar 19 215d
Jan 21 523d
| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 484 | 1 | — | — | $2.42 | $0.10 | — | — | 4 | 0 | |
| 230 | 1 | — | — | $1.92 | $0.05 | -0.07 | 1231% | 4 | 39 | |
| 76 | 2 | 248.2% | 0.992 | $1.72 | $0.05 | — | — | 10 | 9 | |
| 11 | 1 | 232.5% | 0.935 | $1.12 | $0.15 | — | — | 2 | 1 | |
| 454 | 30 | — | — | $0.40 | $0.15 | -0.191 | 177.8% | 2 | 542 | |
| 2.5k | 92 | 67.5% | 0.433 | $0.10 | $0.13 | -0.547 | 83.7% | 736 | 1.5k | |
| 13.5k | 1 | 192.3% | 0.266 | $0.03 | $0.64 | — | — | 100 | 114 | |
| 998 | 1 | 238.4% | 0.181 | $0.05 | $1.17 | -0.914 | 173.2% | 10 | 11 | |
| 140 | 5 | 322.1% | 0.186 | $0.05 | $1.43 | -0.929 | 218.6% | 6 | 2 | |
| 293 | 50 | 368.1% | 0.169 | $0.01 | $2.05 | -0.895 | 304.8% | 2 | 2 | |
| 6 | 1 | — | — | $0.08 | $2.57 | -0.872 | 376.3% | 1 | 0 | |
| 0 | — | — | — | — | $3.07 | — | — | 1 | 0 | |
About this data
Each contract's last price, volume, greeks, implied volatility and open interest belongs to the snapshot session shown in its details; unknown means the provider omitted the timestamp. This chain has mixed snapshot sessions · Jun 18, 2026–Aug 14, 2026; 1 unknown. Cross-contract positioning totals are shown only when every returned row has the same known session. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown.
Key facts
CIK
1326190
CUSIP
02155H200
13F (30d)
201 filings
199 filers
Visit website
Investor relations